Alseres Pharmaceuticals ALSE Stock
Alseres Pharmaceuticals Price Chart
Alseres Pharmaceuticals ALSE Financial and Trading Overview
| Alseres Pharmaceuticals stock price | 0.0050 USD |
| Previous Close | 0.01 USD |
| Open | 0.01 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.01 - 0.01 USD |
| 52 Week Range | 0.01 - 0.01 USD |
| Volume | 38 USD |
| Avg. Volume | 0 USD |
| Market Cap | 398.26K USD |
| Beta (5Y Monthly) | 0.160915 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ALSE Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.8406793 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Alseres Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.160915 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.01 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.01 USD |
| 200-Day Moving Average | 0.01 USD |
ALSE Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 6.13K |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | 0 |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.010% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2013 |
| Most Recent Quarter (mrq) | June 30, 2014 |
| Next Fiscal Year End | December 31, 2014 |
Profitability
| Profit Margin | -163.94% |
| Operating Margin (ttm) | -178.11% |
| Gross Margin | 94.61% |
| EBITDA Margin | -177.98% |
Management Effectiveness
| Return on Assets (ttm) | -247.060% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 473.73K USD |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | 0% |
| Gross Profit (ttm) | 450.04K USD |
| EBITDA | -843188 USD |
| Net Income Avi to Common (ttm) | -776636 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 186.95K USD |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | 8.92M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.121 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1344280 USD |
| Levered Free Cash Flow (ttm) | -2427915 USD |
Profile of Alseres Pharmaceuticals
| Country | United States |
| State | MA |
| City | Auburndale |
| Address | 275 Grove Street |
| ZIP | 02466 |
| Phone | 617-419-3289 |
| Website | https://www.alseres.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
Alseres Pharmaceuticals, Inc. focuses on developing diagnostic and therapeutic products primarily for disorders in the central nervous system. Its lead product candidate is Altropane, a molecular imaging agent for the diagnosis of Parkinson's disease and dementia. The company was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007. Alseres Pharmaceuticals, Inc. was founded in 1972 and is based in Auburndale, Massachusetts.
Q&A For Alseres Pharmaceuticals Stock
What is a current ALSE stock price?
Alseres Pharmaceuticals ALSE stock price today per share is 0.0050 USD.
How to purchase Alseres Pharmaceuticals stock?
You can buy ALSE shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Alseres Pharmaceuticals?
The stock symbol or ticker of Alseres Pharmaceuticals is ALSE.
Which industry does the Alseres Pharmaceuticals company belong to?
The Alseres Pharmaceuticals industry is Biotechnology.
How many shares does Alseres Pharmaceuticals have in circulation?
The max supply of Alseres Pharmaceuticals shares is 39.83M.
What is Alseres Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Alseres Pharmaceuticals PE Ratio is now.
What was Alseres Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Alseres Pharmaceuticals EPS is -0.02 USD over the trailing 12 months.
Which sector does the Alseres Pharmaceuticals company belong to?
The Alseres Pharmaceuticals sector is Healthcare.